New research shows MDMA and psilocybin may restore neural flexibility in people with PTSD, thereby helping the brain unlearn ...

The Food and Drug Administration could approve the first prescription psychedelic therapy as early as this year, and state ...

With Lykos’ regulatory failure now squarely in the rearview mirror, Compass Pathways and Definium are leading what one ...

Sales of Johnson & Johnson’s esketamine-based nasal spray jumped in the fourth quarter last year, priming the pump for a suite of other pharmas, including AbbVie, champing at the bit with their own ...

An estimated 10 million U.S. adults microdosed psilocybin, LSD or MDMA in 2025, according to research published by the ...

Bioxyne CEO and Managing Director Sam Watson talked with Proactive about the company’s major developments across medical ...

He recently ran 500 miles from Colorado Springs to Moab while microdosing psilocybin and other psychedelics, to understand ...

Zucker Hillside Hospital is conducting a study on the effects of alcohol and drugs, including cannabis, psilocybin, and MDMA, ...

How much should psychedelics researchers disclose about their personal use of psilocybin, ketamine, and other drugs?

A top federal health official is again touting the therapeutic “promise” of psychedelics such as psilocybin and MDMA—though ...

Maryland lawmakers have filed bills to extend a psychedelic task force through the end of 2027 to develop updated ...